Clinical Evidence / Publications / Preclinical
Summary
This study introduced Pivot Mandu, a three-layer balloon spacer whose size can be adjusted during the procedure and then sealed for long-term implantation. In bench tests and pig studies lasting up to six months, the balloon inflated remotely as intended and kept its shape and function.
Part of the research behind the Pivot‑TR® platform for tricuspid regurgitation.
Key results
3
layers: inner mesh, compliant balloon, outer e-PTFE
6months
longest animal follow-up
16
pigs studied
20
bench expansion tests
Background
Why this study
Filled spacers must stay leak-tight for years, and fixed-size spacers cannot be tuned to each patient. Pivot Mandu combines a nitinol mesh, a compliant balloon and an e-PTFE cover with a detachable filling system so the operator can set the size and then leave it sealed.
Methods
What was done
- Bench tests checked balloon expansion and size adjustment.
- Survival experiments in 16 pigs ran from 2 weeks to 6 months, with echocardiography and necropsy.
- Animals received anticoagulation during the survival period.
Findings
What was found
- The balloon was inflated remotely and its size could be adjusted easily during the procedure.
- Implanted spacers stayed patent and functional for up to six months.
Interpretation
What it means
Authors’ conclusion
The adjustable, leak-tight 3D balloon spacer showed long-term patency in animals, and the authors recommend moving it into human trials.
Limitations
- Pig anatomy differs from human, notably at the cavotricuspid isthmus
- TR severity graded visually
- Small animal numbers
Overview
Study at a glance
- Type
- Preclinical (bench and animal)
- Device
- Pivot Mandu adjustable 3D balloon spacer
- Model
- Swine
- Follow-up
- 2 weeks to 6 months
Summary written by Tau Medical from the published article. Results from bench, animal or computer studies may not predict outcomes in patients.
Related publications
CCI 2026 · Clinical
Safety and Efficacy of Pivot-Bridge for Severe Functional Tricuspid Regurgitation: The First-in-Human Experiences
View detailsEuroIntervention 2026 · Clinical
A novel spacer for transcatheter treatment of tricuspid regurgitation
View detailsKCJ 2025 · Clinical
